Literature DB >> 27436330

Update on Mineral and Bone Disorders in Chronic Kidney Disease.

Jonathan D Foster1.   

Abstract

The inappropriate phosphorus retention observed in chronic kidney disease is central to the pathophysiology of mineral and bone disorders observed in these patients. Subsequent derangements in serum fibroblast growth factor 23, parathyroid hormone, and calcitriol concentrations play contributory roles. Therapeutic intervention involves dietary phosphorus restriction and intestinal phosphate binders in order to correct phosphorus retention and maintain normocalcemia. Additional therapies may be considered to normalize serum fibroblast growth factor 23 and parathyroid hormone.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fibroblast growth factor 23; Hyperphosphatemia; Renal osteodystrophy; Renal secondary hyperparathyroidism

Mesh：

Year:  2016        PMID： 27436330     DOI： 10.1016/j.cvsm.2016.06.003

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN： 0195-5616            Impact factor:   2.093


  6 in total

1.  Evaluation of renal osteodystrophy in the dental clinic by assessment of mandibular and phalangeal cortical indices.

Authors:  Bruna Corrêa Massahud; João César Guimarães Henriques; Reinhilde Jacobs; Rafaela Rangel Rosa; Caio Vinícius Bardi Matai
Journal:  Oral Radiol       Date:  2017-09-04       Impact factor: 1.852

2.  Symmetric dimethylarginine concentrations in dogs with International Renal Interest Society stage 4 chronic kidney disease undergoing intermittent hemodialysis.

Authors:  André Nanny Vieira Le Sueur; Silvano Salgueiro Geraldes; Alessandra Melchert; Regina Kiomi Takahira; Michael Coyne; Rachel Murphy; Donald Szlosek; Priscylla Tatiana Chalfun Guimarães-Okamoto
Journal:  J Vet Intern Med       Date:  2019-09-12       Impact factor: 3.333

Review 3.  Vitamin D Metabolism and Its Role in Mineral and Bone Disorders in Chronic Kidney Disease in Humans, Dogs and Cats.

Authors:  Fernanda C Chacar; Márcia M Kogika; Rafael V A Zafalon; Marcio A Brunetto
Journal:  Metabolites       Date:  2020-12-04

4.  Bilateral patellar fractures and increased cortical bone thickness associated with long-term oral alendronate treatment in a cat.

Authors:  Nicola Council; Jon Dyce; Wm Tod Drost; Joao Felipe de Brito Galvao; Thomas J Rosol; Dennis J Chew
Journal:  JFMS Open Rep       Date:  2017-08-29

5.  Investigation on urinary and serum alpha klotho in dogs with chronic kidney disease.

Authors:  Hong Jae Yi; Jong Bok Lee; Kyu Pil Lee; Ye-In Oh; Kun Ho Song; Kyoung Won Seo
Journal:  BMC Vet Res       Date:  2020-07-16       Impact factor: 2.741

6.  Effects of calcifediol supplementation on markers of chronic kidney disease-mineral and bone disorder in dogs with chronic kidney disease.

Authors:  Valerie J Parker; Adam J Rudinsky; Jason A Benedict; Azadeh Beizaei; Dennis J Chew
Journal:  J Vet Intern Med       Date:  2020-10-31       Impact factor: 3.333
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.